BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12837603)

  • 1. Prion proteins meet protein quality control.
    Dimcheff DE; Portis JL; Caughey B
    Trends Cell Biol; 2003 Jul; 13(7):337-40. PubMed ID: 12837603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and neurodegeneration in prion diseases.
    Kim JI; Choi SI; Kim NH; Jin JK; Choi EK; Carp RI; Kim YS
    Ann N Y Acad Sci; 2001 Apr; 928():182-6. PubMed ID: 11795509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.
    Ma J; Lindquist S
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14955-60. PubMed ID: 11742063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
    Ma J; Wollmann R; Lindquist S
    Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding and misfolding of the prion protein in the secretory pathway.
    Tatzelt J; Winklhofer KF
    Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond.
    Soto C; Saborio GP; Anderes L
    Trends Neurosci; 2002 Aug; 25(8):390-4. PubMed ID: 12127750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
    Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
    J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion seeded conversion and amplification assays.
    Orrú CD; Caughey B
    Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
    Ma J; Lindquist S
    Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein diversity and disease in the transmissible spongiform encephalopathies.
    Priola SA
    Adv Protein Chem; 2001; 57():1-27. PubMed ID: 11447687
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
    Bate C; Tayebi M; Williams A
    BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
    Jeffrey M; McGovern G; Sisó S; González L
    Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could inhibition of the proteasome cause mad cow disease?
    Hooper NM
    Trends Biotechnol; 2003 Apr; 21(4):144-5. PubMed ID: 12679058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
    Brown DR
    Folia Neuropathol; 2005; 43(4):229-43. PubMed ID: 16416388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone-supervised conversion of prion protein to its protease-resistant form.
    DebBurman SK; Raymond GJ; Caughey B; Lindquist S
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells.
    Cohen E; Taraboulos A
    EMBO J; 2003 Feb; 22(3):404-17. PubMed ID: 12554642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein misfolding and disease: the case of prion disorders.
    Hetz C; Soto C
    Cell Mol Life Sci; 2003 Jan; 60(1):133-43. PubMed ID: 12613663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A receptor for infectious and cellular prion protein.
    Martins VR
    Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.